News

Three men and a woman standing

Future Health joins BioConvergence Cancer Alliance as founding member

Future Health Initiatives

July 3, 2026

The BioConvergence Cancer Alliance at MIT’s Koch Institute is expanding its global network with the addition of a founding member: Future Health – A Global Initiative by Abu Dhabi.The partnership will create new opportunities for collaboration across research, healthcare, and industry, advancing efforts in cancer prevention, earlier detection, and more effective treatments  

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

Showing 751–753 of 753 stories

KI Director to be Named to National Cancer Advisory Board

The White House

September 21, 2011

In the White House announcement of his appointment, Koch Institute Director Tyler Jacks was recognized by the President for his depth of experience and tremendous dedication to cancer research.

Koch Institute and OMJP launch TRANSCEND

MIT News

June 28, 2010

KI announced a major strategic partnership with Ortho-McNeil-Janssen Pharmaceuticals, Inc., and its affiliates, called TRANSCEND, whereby the parties will begin to collaborate in multiple areas of oncology research and technology development.

David H. Koch Gives $100 Million to MIT for Cancer Research

MIT News

October 9, 2007

MIT has announced a $100 million gift from Koch Industries executive and MIT alumnus David H. Koch that will usher in new paradigms in highly integrative cancer research. The gift will bring together MIT scientists and engineers under one roof to develop new and powerful ways to detect, diagnose, treat, and manage this often deadly disease.